Volume 41, Issue 11 p. 1826-1838
RESEARCH ARTICLE

Acute and subacute inhalation toxicity assessment of WS-23 in Sprague–Dawley rats

Ze-Hong Wu

Ze-Hong Wu

RELX Lab, Shenzhen RELX Tech. Co,. Ltd., Shenzhen, China

Search for more papers by this author
Yue-Song Liu

Yue-Song Liu

Drug Evaluation Center, Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd., Guangzhou, China

Search for more papers by this author
Xin-Duo Li

Xin-Duo Li

RELX Lab, Shenzhen RELX Tech. Co,. Ltd., Shenzhen, China

Search for more papers by this author
Te Xu

Te Xu

RELX Lab, Shenzhen RELX Tech. Co,. Ltd., Shenzhen, China

Search for more papers by this author
Jing Xu

Jing Xu

RELX Lab, Shenzhen RELX Tech. Co,. Ltd., Shenzhen, China

Search for more papers by this author
Xue-Min Yang

Xue-Min Yang

RELX Lab, Shenzhen RELX Tech. Co,. Ltd., Shenzhen, China

Search for more papers by this author
Ren-Qiang Ma

Ren-Qiang Ma

Drug Evaluation Center, Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd., Guangzhou, China

Search for more papers by this author
Xing-Tao Jiang

Corresponding Author

Xing-Tao Jiang

RELX Lab, Shenzhen RELX Tech. Co,. Ltd., Shenzhen, China

Correspondence

Xing-Tao Jiang, RELX Lab, Shenzhen RELX Tech. Co,. Ltd., Shenzhen, China.

Email: [email protected]

Search for more papers by this author
First published: 23 March 2021
Citations: 7
This article was published online on 23 March 2021. Subsequently, an author's name was corrected, and the revision was published on 8 April 2021.

Funding information: The Science Fund of RELX, Grant/Award Number: RELX-2020-003

Abstract

2-isopropyl-N,2,3-trimethylbutyramide (WS-23) is a well-known artificial synthesis cooling agent widely used in foods, medicines, and tobaccos. As a commonly cooling agent in e-cigarette liquids, WS-23 has led to concerns about the inhalation toxicity with the prosperous of e-cigarettes in recent years. Thus, the aim of this study is to assess the acute and subacute inhalation toxicity of WS-23 in Sprague–Dawley (SD) rats according to the Organization for Economic Cooperation and Development (OECD) guidelines. In the acute toxicity study, there was no mortality and behavioral signs of toxicity at the limit test dose level (340.0 mg/m3) in the exposure period and the following 14-day observation period. In the subacute inhalation toxicity study, there was no significant difference observed in the body weights, feed consumption, and relative organ weights. Haematological, serum biochemical, urine, and bronchoalveolar lavage fluid (BALF) analysis revealed the non-adverse effects after 28-day repeated WS-23 inhalation (342.85 mg/m3), accompanied by slight changes in few parameters which returned to normal during the 28-day recovery period. The histopathologic examination also did not show any differences in vital organs. In conclusion, the maximum tolerated dose for WS-23 acute inhalation is not less than 340.0 mg/m3, and the No Observed Adverse Effect Level (NOAEL) of WS-23 subacute inhalation was determined to be over 342.85 mg/m3.

CONFLICT OF INTEREST

The authors declare that there are no conflicts of interest.